Microalbuminuria In Essential Hypertension
Microalbuminuria In Essential Hypertension
DOI:
https://doi.org/10.70284/njirm.v5i1.2282Keywords:
Blood Pressure, Hypertension, Microalbuminuria(MAU), Target Organ Damage (TOD)Abstract
Background & objectives: Microalbuminuria has been described as an early sign of vascular damage in certain high risk goups such as diabetes, hypertension & family history of cardiovascular renal disease. In diabetes mellitus the prognostic value of microalbuminuria as a marker of early nephropathy and increased cardiovascular risk has been well established. The aim of this study is to establish the prevalence of microalbuminuria in nondiabetic essential hypertensive patients and its relation with target organ damage. Material and Methods: 100 non diabetic essential hypertensive patients attending OPD as well as admitted in the tertiary care hospital of Jamnagar were included in this study. They underwent detailed clinical examination. A single early morning urine sample was used to measure microalbuminuria by Micral test strip and urine creatinine was measured to establish albumin creatinine ratio. Results: The age of patients selected for study varied from 35 to 76 years; mean age being 51.5 years. 52% were males and mean duration of hypertension was 3.9 +/- 3.9 yrs. Microalbuminuria was found in 46% of the patients and showed significant association with male gender (p=0.001), age (p<0.05) & target organ damage in any form (p<0.05). Interpretation and conclusion: Measuring urinary albumin excretion (UAE), a simple, low cost and readily available test, can be regarded as a cost effective way to identify nondiabetic essential hypertensives at high risk and can thus help to prevent the development of complications by aggressive treatment to get down to target blood pressure.
References
2. Leoncini G, Sacchi G, Ravera M et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J. of Human Hypertension 2002; 16: 399-404.
3. Hoegholm A, Bang LE, Kristensen KS, Neilsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension Jul 1994; 24(1): 101-5.
4. Freedman BI, Beck SR, Rich SS. Meiss G, Lewis CE. A Genome wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42: 291-296.
5. Bangstad HJ, Kenneth T, Jorgensen KD, Hanssen KF. New semiquantitative dipstick test for microalbuminuria. Diabetes Care 1991; 14: 1094–1097
6. Poulsen PL, Hansen B, Amby T, Terkelsen T, Mogensen CE. Evaluation of a dipstick test for microalbuminuria in three different clinical settings, including the correlation with urinary albumin excretion rate. Diabete Metab 1992; 18: 395–400
7. Minetti EE, Cozzi MG, Granata S and Guidi E. Accuracy of the urinary albumin titrator stick ‘Micral-Test’in kidney-disease patients. Nephrol Dial Transplant 1997; 12: 78–80
8. Mogensen CE : Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas in : the kidney and hypertension in diabetes Mellitus : Edited by Mogensen Boston. Kluwer academic Publishers 2000: 655-706.
9. Thomas SM, Viberti GC. Is it possible to predict diabetic kidney disease (Review). J Endocrinol 2000; 23: 44-53.
10. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97.
11. Verdecchia P and Reboldi GP. Hypertension and microalbuminuria: the new
detrimental duo. Blood Pressure 2004; 4(13): 198-211.
12. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC study. A Genoa investigation on complications. Hypertension 1997; 30(5): 1135-1145.
13. Badiger S, Sandeep HM, Talikoti SC, Biradar MS. A study of microalbuminuria and target organ damage in patients with essential hypertension. Int J Biol Med Res. 2012; 3(1):1351-1355
14. Bacanu EV, Bacanu ME, Botez C. Microalbuminuria in essential hypertension at patients with or without type 2 diabetes.Proc. Rom. Acad., Series B 2011; 2: 145-154.
15. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension.J Hypertens Feb1996; 14 (2): 223-8.
16. Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna CD, Jayaprakash K et al. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: An Indian Experience. Saudi J Kidney Dis Trannspl 2008; 19 (3): 411-419.
17. Rodicio JL, Campo C, Ruilope LM : Microalbuminuria in essential hypertension. Kidney International 1998; 54(Suppl.68): 51-54.
18. Ruilope LM, Alcazar JM, Rodicio JL : Renal consequences of arterial hypertension. J Hypertens 1992; 10(suppl.7): 85-90.
19. Cottone S, Cerasola G. Microalbuminuria fractional clearance and early renal permselectivity changes in essential hypertension. Am J Nephrol 1992; 12: 326-329.
20. Ruilope LM, Alcazar JM, Hernandez E, Praga M, Lahera V, Rodicio JL. Long term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994; 45 (suppl.45): 171-173.
21. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful inpredicting risk for coronary heart disease ? The Framingham Heart Study. Circulation 1999; 100: 354-360.
22. Viazzi F, Leoncini G, Parodi D et al. Pulse pressure and subclinical cardiovascular damage in primary hypertension. Nephrol Dial Transplant 2002; 17: 1779-1785.
23. Crillo M, Stellato D, Laurenzi M, Panarelli W, Zancheti A, and Santo NG. The Gubbio study collaborative research group. Pulse pressure and isolated systolic hypertension. Association with Microalbuminuria. Kidney International 2000; 58: 1211-1218.
24. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all cause mortality, especially among hypertensive subjects. Five year follow up of the Hoorn study. Arterioscler Thromb. Vasc Biol 1999; 19: 617-624.
25. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Scroll M, Jensen JS. Urinary albumin excretion : an independent predictor of ischaemic heart disease. Arterioscler Thromb. Vasc Biol 1999; 19: 1992-1997.
26. Sainani GS, Maru GV. Role of endothelial cell dysfunction in essential hypertension. JAPI.2004; 52: 966- 969
